Why Haemonetics Stock Fell 13% Today

Why Haemonetics Stock Fell 13% Today
·1 min read

Investors were not kind to Haemonetics (NYSE: HAE) on Thursday, trading the stock down by more than 13%. The sell-off occurred in the wake of the blood and plasma collection systems company's 2021 earnings release for the fiscal fourth quarter of 2021. The quarter saw Haemonetics earn $221 million in revenue, down 6% on a year-over-year basis.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting